DuPont (DD) Names Matthias Heinzel As President Of Dupont Nutrition & Health Following Retirement Of Craig F. Binetti

WILMINGTON, Del.Dec. 4, 2014 /PRNewswire/ -- Today DuPont announced that it has named Matthias Heinzel, president, DuPont Nutrition & Health effective Jan. 1, 2015, succeeding Craig F. Binetti who is retiring following 38 years of service to the company.

"Craig has served as an outstanding business leader at DuPont. Throughout his career, he has had a talent for leading people, being a role model for our core values and generating business success," said DuPont Executive Vice President James C. Borel. "Craig has earned the deep trust and respect from all who worked with him over 38 years.  We are deeply grateful for his years of leadership and service, and wish him all of the best.

"Matthias brings global business experience with a proven success record in building competitive advantage, setting strategy and direction and creating profitable growth.  He will help drive the Nutrition & Health business as a leading food ingredients and food safety solutions provider to the food and beverages industries worldwide."

Heinzel joined DuPont in 2003 following prior leadership roles in the telecommunications industry and at McKinsey & Company. Heinzel has held several business leadership roles in DuPont Imaging Technologies, Authentication and Packaging Graphics. In 2013 he was appointed global business director, Enablers, DuPont Nutrition & Health, where he has been leading significant business improvement.

Binetti joined DuPont in 1977 where his early career spanned a variety of professional and managerial positions covering research, manufacturing, finance, sales, marketing and business positions in the Chemicals, Pigments, Elastomers, Polymers and Fiber businesses. From 1991 to 1998, Binetti held a number of positions in the paper, film and resins businesses in the United States and in Europe. From 1998 to 2002 he was vice president and general manager of Polyester Fibers, Resins & Intermediates. In March 2002 he was named vice president and general manager of DuPont Packaging & Industrial Polymers. In June 2007 he was named president of DuPont Nutrition & Health and chairman of Solae.  In September 2009he added responsibility for DuPont Applied BioSciences, and was named to his current position in May 2011. 

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders, we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

NYC’s outstanding talent and funding, the city is rich with life science real estate offerings across the five boroughs.

Sutro Biopharma’s lead antibody-drug conjugate shrank tumors in 13% of patients with ovarian cancer who had tried a median of six other treatments.

Immuno-oncology biotech Silverback Therapeutics has more than doubled its original IPO hopes.